Updated: Jul 12, 2021
A joint, academic-industrial postdoctoral position in the area of oligonucleotide, nanomaterial-based devices is now open. This collaborative project will be aimed at the development of new methods and materials for the rapid diagnosis of infectious diseases such as COVID-19. The candidate will split their time conducting research at McGill University (Damha-Luedtke Labs) and the Montreal-based biotech company Galenvs under the direction of Dr. Jamal Daoud.
Skills and Experience The candidate is required to have recently completed a PhD degree in chemistry, preferably with extensive experience in the synthesis and purification of oligonucleotides. The candidate must be able to work both independently and as part of a team, and they must be able to conduct in-person research while adhering to special COVID-19 safety protocols.
Research Project Quantitative, real-time PCR (qPCR) is the “gold-standard” test for the detection of active viral infections, such as SARS-CoV-2 for the diagnosis of COVID-19. No other method can match the sensitivity and specificity of this approach. However, qPCR requires highly trained personal and advanced lab equipment to conduct. As such, sample processing times are often long, and qPCR can’t fully serve the needs of rural, primary-care physicians in developing countries. In this collaborative research project, novel devices and materials for isothermal amplification and detection of viral genomes will be developed for simple, kit-based diagnostic devices for world-wide distribution. A combination of fundamental research, materials production, device construction, and functional testing will be required for success.
Application Procedure Candidates are asked to submit a CV and cover letter to Prof. Nathan Luedtke (email@example.com). Requests for two reference letters will be made shortly after the initial selection round, and interviews conducted by video conferencing. We welcome applications from Aboriginal persons, persons with disabilities, ethnic minorities, persons of minority sexual orientation or gender identity, visible minorities, women and others who may contribute to diversification. All qualified applicants are encouraged to apply, although Canadians and permanent residents will be given priority.